Leveraging fluorinated glucosamine action to boost anti-tumor immunity

Autor Dimitroff, Charles J.
Vydáno 2012

Galectin-binding O-glycosylations as Regulators of Malignancy()

Autor Dimitroff, Charles J.
Vydáno v Cancer Res (2015)

I-branched carbohydrates as emerging effectors of malignant progression

Autor Dimitroff, Charles J.
Vydáno v Proc Natl Acad Sci U S A (2019)

Cancer immunotherapy needs to learn how to stick to its guns

Autor Chakraborty, Asmi, Dimitroff, Charles J.
Vydáno v J Clin Invest (2019)

Galectin-1 research in T cell immunity: Past, present and future

Autor Cedeno-Laurent, Filiberto, Dimitroff, Charles J.
Vydáno 2011

Galectins and their ligands: negative regulators of anti-tumor immunity

Autor Cedeno-Laurent, Filiberto, Dimitroff, Charles J.
Vydáno 2012

Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen

Autor Dimitroff, Charles J., Kupper, Thomas S., Sackstein, Robert
Vydáno 2003

Analysis of Physiologic E-Selectin-Mediated Leukocyte Rolling on Microvascular Endothelium

Autor Wiese, Georg, Barthel, Steven R., Dimitroff, Charles J.
Vydáno 2009

Galectin-Glycan Interactions as Regulators of B Cell Immunity

Autor Giovannone, Nicholas, Smith, Logan K., Treanor, Bebhinn, Dimitroff, Charles J.
Vydáno v Front Immunol (2018)

A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells

Autor Dimitroff, Charles J., Lee, Jack Y., Fuhlbrigge, Robert C., Sackstein, Robert
Vydáno 2000

Targeting selectins and selectin ligands in inflammation and cancer

Autor Barthel, Steven R, Gavino, Jacyln D, Descheny, Leyla, Dimitroff, Charles J
Vydáno 2007

Cd44 Is a Major E-Selectin Ligand on Human Hematopoietic Progenitor Cells

Autor Dimitroff, Charles J., Lee, Jack Y., Rafii, Shahin, Fuhlbrigge, Robert C., Sackstein, Robert
Vydáno 2001

Galectin-1 triggers an immunoregulatory signature in T helper cells functionally defined by IL-10 expression

Autor Cedeno-Laurent, Filiberto, Opperman, Matthew, Barthel, Steven R., Kuchroo, Vijay K., Dimitroff, Charles J.
Vydáno 2012

Skin-Homing Receptors on Effector Leukocytes Are Differentially Sensitive to Glyco-Metabolic Antagonism in Allergic Contact Dermatitis

Autor Gainers, Madeliene E., Descheny, Leyla, Barthel, Steven R., Liu, Luzheng, Wurbel, Marc-André, Dimitroff, Charles J.
Vydáno 2007

Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma

Autor Cedeno-Laurent, Filiberto, Watanabe, Rei, Teague, Jessica E., Kupper, Thomas S., Clark, Rachael A., Dimitroff, Charles J.
Vydáno 2012

Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin

Autor Barthel, Steven R, Gavino, Jacyln D, Wiese, Georg K, Jaynes, Jennifer M, Siddiqui, Javed, Dimitroff, Charles J
Vydáno 2008

Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression

Autor Yamanaka, Kei-ichi, Dimitroff, Charles J., Fuhlbrigge, Robert C., Kakeda, Masato, Kurokawa, Ichiro, Mizutani, Hitoshi, Kupper, Thomas S.
Vydáno 2007

Development of a Nascent Galectin-1 Chimeric Molecule for Studying the Role of Leukocyte Galectin-1 Ligands and Immune Disease Modulation

Autor Cedeno-Laurent, Filiberto, Barthel, Steven R., Opperman, Matthew J., Lee, David M., Clark, Rachael A., Dimitroff, Charles J.
Vydáno 2010

Identification of Leukocyte E-selectin Ligands, P-selectin Glycoprotein Ligand-1 and E-selectin Ligand-1, on Human Metastatic Prostate Tumor Cells

Autor Dimitroff, Charles J., Descheny, Leyla, Trujillo, Natalia, Kim, Robert, Nguyen, Vuong, Huang, Wei, Pienta, Kenneth J., Kutok, Jeffery L., Rubin, Mark A.
Vydáno 2005

Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways.

Autor Chakraborty, Asmi, Staudinger, Caleb, King, Sandra L., Erickson, Frances Clemente, Lau, Lee Seng, Bernasconi, Angela, Luscinskas, Francis W., Perlyn, Chad, Dimitroff, Charles J.
Vydáno v J Autoimmun (2020)